Simple and Rapid InVivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology

Cell Reports

Volumn 9, Issue 4, 2014, Pages 1219-1227

  Blasco, Rafael B ^a   Karaca, Elif ^a   Ambrogio, Chiara ^b   Cheong, Taek Chin ^a   Karayol, Emre ^a   Minero, Valerio G ^c   Voena, Claudia ^a,c   Chiarle, Roberto ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Centro Nacional de Investigations Oncológicas   (Spain)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; MESSENGER RNA; CRISPR ASSOCIATED PROTEIN; ONCOPROTEIN;

ADULT; ALK GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CRISPR CAS SYSTEM; CRISPR CAS9 SYSTEM; EMBRYO; EML4 GENE; GENE; GENE FUSION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; RNA EDITING; RNA SEQUENCE; ANIMAL; CARCINOGENESIS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE TRANSLOCATION; GENETICS; HEK293 CELL LINE; LUNG TUMOR; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROCEDURES;

ANIMALS; BASE SEQUENCE; CARCINOGENESIS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEINS; GENE REARRANGEMENT; GENETIC ENGINEERING; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MICE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; RNA, MESSENGER; TRANSLOCATION, GENETIC;

EID: 84912078930     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.10.051     Document Type: Article

References (43)

1. Alt F.W., Zhang Y., Meng F.L., Guo C., Schwer B. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 2013, 152:417-429.
2. Blasco R.B., Francoz S., Santamaría D., Cañamero M., Dubus P., Charron J., Baccarini M., Barbacid M. c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. Cancer Cell 2011, 19:652-663.
3. Boboila C., Alt F.W., Schwer B. Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks. Adv. Immunol. 2012, 116:1-49.
4. Brunet E., Simsek D., Tomishima M., DeKelver R., Choi V.M., Gregory P., Urnov F., Weinstock D.M., Jasin M. Chromosomal translocations induced at specified loci in human stem cells. Proc. Natl. Acad. Sci. USA 2009, 106:10620-10625.
5. Chen Z., Sasaki T., Tan X., Carretero J., Shimamura T., Li D., Xu C., Wang Y., Adelmant G.O., Capelletti M., et al. Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene. Cancer Res. 2010, 70:9827-9836.
6. Chiarle R., Voena C., Ambrogio C., Piva R., Inghirami G. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat. Rev. Cancer 2008, 8:11-23.
7. Chiarle R., Zhang Y., Frock R.L., Lewis S.M., Molinie B., Ho Y.J., Myers D.R., Choi V.W., Compagno M., Malkin D.J., et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 2011, 147:107-119.
8. Choi P.S., Meyerson M. Targeted genomic rearrangements using CRISPR/Cas technology. Nat Commun 2014, 5:3728.
9. Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
10. Duan J., Lu G., Xie Z., Lou M., Luo J., Guo L., Zhang Y. Genome-wide identification of CRISPR/Cas9 off-targets in human genome. Cell Res. 2014, 24:1009-1012.
11. Gilbert L.A., Larson M.H., Morsut L., Liu Z., Brar G.A., Torres S.E., Stern-Ginossar N., Brandman O., Whitehead E.H., Doudna J.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-451.
12. Gostissa M., Alt F.W., Chiarle R. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu. Rev. Immunol. 2011, 29:319-350.
13. Gostissa M., Schwer B., Chang A., Dong J., Meyers R.M., Marecki G.T., Choi V.W., Chiarle R., Zarrin A.A., Alt F.W. IgH class switching exploits a general property of two DNA breaks to be joined incis over long chromosomal distances. Proc. Natl. Acad. Sci. USA 2014, 111:2644-2649.
14. Gupta A., Hall V.L., Kok F.O., Shin M., McNulty J.C., Lawson N.D., Wolfe S.A. Targeted chromosomal deletions and inversions in zebrafish. Genome Res. 2013, 23:1008-1017.
15. Hakim O., Resch W., Yamane A., Klein I., Kieffer-Kwon K.R., Jankovic M., Oliveira T., Bothmer A., Voss T.C., Ansarah-Sobrinho C., et al. DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature 2012, 484:69-74.
16. Hsu P.D., Scott D.A., Weinstein J.A., Ran F.A., Konermann S., Agarwala V., Li Y., Fine E.J., Wu X., Shalem O., et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013, 31:827-832.
17. Jao L.E., Wente S.R., Chen W. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc. Natl. Acad. Sci. USA 2013, 110:13904-13909.
18. Klein I.A., Resch W., Jankovic M., Oliveira T., Yamane A., Nakahashi H., Di Virgilio M., Bothmer A., Nussenzweig A., Robbiani D.F., et al. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 2011, 147:95-106.
19. Kuscu C., Arslan S., Singh R., Thorpe J., Adli M. Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat. Biotechnol. 2014, 32:677-683.
20. Lee H.J., Kweon J., Kim E., Kim S., Kim J.S. Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases. Genome Res. 2012, 22:539-548.
21. Long C., McAnally J.R., Shelton J.M., Mireault A.A., Bassel-Duby R., Olson E.N. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science 2014, 345:1184-1188.
22. Maddalo D., Manchado E., Concepcion C.P., Bonetti C., Vidigal J.A., Han Y.C., Ogrodowski P., Crippa A., Rekhtman N., de Stanchina E., et al. Invivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 2014, Published online October 22, 2014. 10.1038/nature13902.
23. Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
24. Mano H. Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer. Cancer Sci. 2008, 99:2349-2355.
25. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7:233-245.
26. Onn A., Isobe T., Itasaka S., Wu W., O'Reilly M.S., Ki Hong W., Fidler I.J., Herbst R.S. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin. Cancer Res. 2003, 9:5532-5539.
27. Piganeau M., Ghezraoui H., De Cian A., Guittat L., Tomishima M., Perrouault L., René O., Katibah G.E., Zhang L., Holmes M.C., et al. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Res. 2013, 23:1182-1193.
28. Platt R.J., Chen S., Zhou Y., Yim M.J., Swiech L., Kempton H.R., Dahlman J.E., Parnas O., Eisenhaure T.M., Jovanovic M., et al. CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling. Cell 2014, 159:440-455.
29. Rabbitts T.H., Appert A., Chung G., Collins E.C., Drynan L., Forster A., Lobato M.N., McCormack M.P., Pannell R., Spandidos A., et al. Mouse models of human chromosomal translocations and approaches to cancer therapy. Blood Cells Mol. Dis. 2001, 27:249-259.
30. Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013, 8:2281-2308.
31. Shaw A.T., Engelman J.A. ALK in lung cancer: past, present, and future. J.Clin. Oncol. 2013, 31:1105-1111.
32. Simpson A.J., Wallace W.A., Marsden M.E., Govan J.R., Porteous D.J., Haslett C., Sallenave J.M. Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection. J.Immunol. 2001, 167:1778-1786.
33. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., Fujiwara S., Watanabe H., Kurashina K., Hatanaka H., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
34. Soda M., Takada S., Takeuchi K., Choi Y.L., Enomoto M., Ueno T., Haruta H., Hamada T., Yamashita Y., Ishikawa Y., et al. A mouse model for EML4-ALK-positive lung cancer. Proc. Natl. Acad. Sci. USA 2008, 105:19893-19897.
35. Torres R., Martin M.C., Garcia A., Cigudosa J.C., Ramirez J.C., Rodriguez-Perales S. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nat Commun 2014, 5:3964.
36. Wang H., Yang H., Shivalila C.S., Dawlaty M.M., Cheng A.W., Zhang F., Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013, 153:910-918.
37. Wu X., Scott D.A., Kriz A.J., Chiu A.C., Hsu P.D., Dadon D.B., Cheng A.W., Trevino A.E., Konermann S., Chen S., et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol. 2014, 32:670-676.
38. Xiao A., Wang Z., Hu Y., Wu Y., Luo Z., Yang Z., Zu Y., Li W., Huang P., Tong X., et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res. 2013, 41:e141.
39. Xue W., Chen S., Yin H., Tammela T., Papagiannakopoulos T., Joshi N.S., Cai W., Yang G., Bronson R., Crowley D.G., et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 2014, 514:380-384.
40. Yang H., Wang H., Shivalila C.S., Cheng A.W., Shi L., Jaenisch R. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 2013, 154:1370-1379.
41. Yin H., Xue W., Chen S., Bogorad R.L., Benedetti E., Grompe M., Koteliansky V., Sharp P.A., Jacks T., Anderson D.G. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 2014, 32:551-553.
42. Zarrin A.A., Del Vecchio C., Tseng E., Gleason M., Zarin P., Tian M., Alt F.W. Antibody class switching mediated by yeast endonuclease-generated DNA breaks. Science 2007, 315:377-381.
43. Zhang Y., McCord R.P., Ho Y.J., Lajoie B.R., Hildebrand D.G., Simon A.C., Becker M.S., Alt F.W., Dekker J. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 2012, 148:908-921.